Q9CXX9
Gene name |
Cuedc2 |
Protein name |
CUE domain-containing protein 2 |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:67116 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9CXX9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9CXX9-F1 | Predicted | AlphaFoldDB |
14 variants for Q9CXX9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs13474484 | 13 | T>A | No | EVA | |
| rs3408171137 | 34 | Y>S | No | EVA | |
| rs3389546235 | 55 | E>V | No | EVA | |
| rs47481773 | 114 | P>L | No | EVA | |
| rs3389510044 | 119 | K>R | No | EVA | |
| rs230719017 | 147 | D>N | No | EVA | |
| rs3409123846 | 155 | T>A | No | EVA | |
| rs3413037235 | 158 | M>I | No | EVA | |
| rs237788701 | 186 | G>R | No | EVA | |
| rs3389553663 | 209 | L>* | No | EVA | |
| rs3389499988 | 234 | P>T | No | EVA | |
| rs3389548800 | 239 | K>M | No | EVA | |
| rs3389548808 | 274 | N>I | No | EVA | |
| rs3389537803 | 276 | K>T | No | EVA |
No associated diseases with Q9CXX9
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| ubiquitin binding | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of cytokine production involved in inflammatory response | Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response. |
| negative regulation of macrophage cytokine production | Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MELERIVGSA | LLTFVQAHLP | EADLSGLDEV | IFSYVLGVLE | DLGPSGPSEE | NFDMEAFTEM |
| 70 | 80 | 90 | 100 | 110 | 120 |
| MEAYVPGFAH | IPRGIIGDMM | QKLSVQLSDA | RNKENLHPQS | SCVQGQVPIF | PETPRQAEKL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| EEESRPPAAP | GNTLDEAAAA | EELPGVDVLL | EVFPTCSMEQ | AQWVLAKARG | DLEEAVHMLV |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EGKEEGPPGW | DGPSQDLPRR | LRGPQKDDLK | SFILQKYMMV | DRAEDQKTHR | PMAPKEAPKK |
| 250 | 260 | 270 | 280 | ||
| LIRYIDNQVV | STKGERFKDV | RNPEAEEMKA | TYINLKPARK | YRFH |